CNDP2

Across TCGA pan-cancer cohorts, CNDP2 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of CNDP2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CNDP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CNDP2 is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

KIRC, KICH, and THCA are the cancer types where CNDP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CNDP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.989	<.001	12	view →
KICH	Female	III,IV	−2.473	<.001	11	view →
THCA	All	All	−0.309	<.001	9	view →
BRCA	All	All	+0.461	<.001	6	view →
COAD	All	All	−0.288	.011	5	view →
LUSC	Male	All	−0.344	.003	4	view →
STAD	All	II,III,IV	+0.736	.019	3	view →
HNSC	All	All	+0.425	.009	3	view →
UCEC	All	III,IV	+0.982	.048	2	view →
PAAD	All	All	−0.950	.011	2	view →
CHOL	All	All	+0.898	.002	2	view →
PRAD	All	All	+0.321	.018	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

CNDP2–KIRC

Open the KIRC breakdown →